Cargando…

Patients with hypertrophic cardiomyopathy (HCM) and HCM gene carriers have attenuated myocardial oxygenation response to vasodilator stress - a potential mechanism for sudden cardiac death

Detalles Bibliográficos
Autores principales:	Dass, Sairia, Karamitsos, Theodoros, Suttie, Joseph, Sever, Emily, Jerosch-Herold, Michael, Watkins, Hugh, Neubauer, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305146/ http://dx.doi.org/10.1186/1532-429X-14-S1-P157

Ejemplares similares

Blunted Myocardial Oxygenation Response During Vasodilator Stress in Patients With Hypertrophic Cardiomyopathy
por: Karamitsos, Theodoros D., et al.
Publicado: (2013)

Patients with Dilated Cardiomyopathy (DCM) have appropriate myocardial oxygenation response to vasodilator stress
por: Dass, Sairia, et al.
Publicado: (2013)

Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM)
por: Almeida, Dirceu Rodrigues
Publicado: (2019)

Vigorous Exercise in Patients with Hypertrophic Cardiomyopathy: Results of the Prospective, Observational, Multinational, “Lifestyle and Exercise in HCM” (LIVE-HCM) Study
por: Lampert, Rachel, et al.
Publicado: (2023)

Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease
por: Melas, Marilena, et al.
Publicado: (2022)

External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Histopathology in HCM
por: Tejado, Beatriz San Millán, et al.
Publicado: (2018)

Global extracellular volume (ECVglobal) in HCM - the "next generation" test for risk in hypertrophic cardiomyopathy?
por: Sado, Daniel, et al.
Publicado: (2013)

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy
por: Dass, Sairia, et al.
Publicado: (2012)

Prediction of thrombo‐embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk‐CVA)
por: Guttmann, Oliver P., et al.
Publicado: (2015)

Feline Hypertrophic Cardiomyopathy: A Spontaneous Large Animal Model of Human HCM
por: Freeman, Lisa M., et al.
Publicado: (2017)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
por: O'Hanlon, Rory, et al.
Publicado: (2009)

Quality of life and societal costs in hypertrophic cardiomyopathy: protocol of the AFFECT-HCM study
por: Schoonvelde, Stephan A. C., et al.
Publicado: (2023)

Adult Onset Hypertrophic Cardiomyopathy (HCM) Not Detected by Echocardiogram: A Case Presentation
por: Elsouri, Kawther N, et al.
Publicado: (2023)

Derangement of cardiac energy metabolism is acutely exacerbated during exercise in hypertrophic cardiomyopathy, independent of hypertrophy or late gadolinium burden
por: Dass, Sairia, et al.
Publicado: (2012)

The Feline Cardiomyopathies: 3. Cardiomyopathies other than HCM
por: Kittleson, Mark D, et al.
Publicado: (2021)

Venous dysfunction in obstructive hypertrophic cardiomyopathies: Results from the “HCM-Vein” pilot study
por: Réant, Patricia, et al.
Publicado: (2023)

Identification of Potential miRNA-mRNA Regulatory Network Contributing to Hypertrophic Cardiomyopathy (HCM)
por: Wang, Lin, et al.
Publicado: (2021)

Follow-up and prognosis of HCM
por: Dominguez, Fernando, et al.
Publicado: (2018)

Cardiac magnetic resonance imaging (CMR) characteristics in apical versus non-apical hypertrophic cardiomyopathy (HCM)
por: Dastidar, Amardeep Ghosh, et al.
Publicado: (2016)

Clinical Application of the HCM-AF Risk Score in the Prediction of Clinical Outcomes of Polish Patients with Hypertrophic Cardiomyopathy
por: Stec, Maria, et al.
Publicado: (2023)

Foreword to the Special Issue: HCM in 2018
por: Elliott, Perry
Publicado: (2018)

Sudden Cardiac Death Risk over Time in HCM Patients with Implantable Cardioverter-Defibrillator
por: Klopotowski, Mariusz, et al.
Publicado: (2022)

Successful knock-in of Hypertrophic Cardiomyopathy-mutation R723G into the MYH7 gene mimics HCM pathology in pigs
por: Montag, J., et al.
Publicado: (2018)

Machine Learning Methods for Identifying Atrial Fibrillation Cases and Their Predictors in Patients With Hypertrophic Cardiomyopathy: The HCM-AF-Risk Model
por: Bhattacharya, Moumita, et al.
Publicado: (2021)

International HCM Workshop: Innovative Time Integrators
Publicado: (1996)

Perspectives on current recommendations for genetic testing in HCM
por: Monserrat, Lorenzo
Publicado: (2018)

Late gadolinium enhancement (LGE) on Cardiac MR is a powerful predictor of death and “hard” events in patients with hypertrophic cardiomyopathy (HCM)
por: Bhatti, Sabha, et al.
Publicado: (2012)

Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy
por: Kübler, J., et al.
Publicado: (2021)

Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM Trial
por: Reaney, Matthew, et al.
Publicado: (2022)

Regional adenosine-induced hypoperfusion without hyperenhancement on LGE-MRI in young HCM patients: comparison to subjects at risk of HCM and healthy volunteers
por: Jablonowski, Robert, et al.
Publicado: (2015)

Comparison of global extracellular volume (ECV) and late gadolinium enhancement (LGE) to predict the estimated 5 year risk of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM)
por: Avanesov, Maxim, et al.
Publicado: (2016)

Ischaemia as a cause of LVOT gradient reversal in HCM
por: Demetrescu, Camelia, et al.
Publicado: (2017)

Mitochondrial Localization of the Yeast Forkhead Factor Hcm1
por: Rodríguez Colman, María José, et al.
Publicado: (2020)

MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM
por: Li, Mengmeng, et al.
Publicado: (2018)

EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic Cardiomyopathy (ELUCIDATE HCM): A prospective observational study on incidence of arrhythmias
por: Magnusson, Peter, et al.
Publicado: (2020)

Association between Lifelong Physical Activity and Disease Characteristics in HCM
por: AENGEVAEREN, VINCENT L., et al.
Publicado: (2019)

New evidences recommend an active lifestyle in young HCM patients
por: Pelliccia, Antonio
Publicado: (2022)

Cardiac energy metabolism and oxygenation during exercise in the hypertensive heart
por: Dass, Sairia, et al.
Publicado: (2014)

Exercise training improves cardiac function, quality of life and exercise capacity in patients with dilated cardiomyopathy
por: Holloway, Cameron J, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9p4snnkigicrll8f9tajnh4tdl